Aetherus
1 known investors
Aetherus is developing a pocket-sized, non-pharmaceutical handheld device that provides positive-pressure breathing support to give rapid relief from acute breathlessness in about 2-3 minutes for patients with moderate to very severe COPD. The device, still under regulatory development, targets the roughly 66 million COPD patients in the US, EU, and China who experience persistent breathlessness.
Digital HealthHardwareMedical Devices